Literature DB >> 8198049

Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome.

M G Traber1, T D Schiano, A C Steephen, H J Kayden, M Shike.   

Abstract

A water-soluble form of vitamin E, tocopheryl succinate polyethylene glycol 1000 (TPGS), was used as an oral vitamin E supplement in a 71-y-old patient with severe fat malabsorption and vitamin E deficiency secondary to short-bowel syndrome. An absorption test with deuterium-labeled TPGS demonstrated that TPGS was absorbed and the released alpha-tocopherol was transported normally in lipoproteins. The disappearance portion of the deuterated alpha-tocopherol curves were parallel to those in control subjects, suggesting normal metabolic turnover of alpha-tocopherol. Long-term (3 y) supplementation with orally administered TPGS (10,360 mg or 4000 IU/d) maintained normal plasma alpha-tocopherol concentrations, raised adipose tissue alpha-tocopherol concentrations, and prevented further progression of the neurological abnormalities resulting from vitamin E deficiency. Thus, TPGS can be an effective vitamin E supplement in short-bowel syndrome despite severe fat malabsorption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198049     DOI: 10.1093/ajcn/59.6.1270

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  10 in total

Review 1.  Determinants of antioxidant status in humans.

Authors:  A M Papas
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

2.  Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol?

Authors:  Evelyn I Back; Claudia Frindt; Erika Oćenásková; Donatus Nohr; Martin Stern; Hans K Biesalski
Journal:  Eur J Nutr       Date:  2005-03-22       Impact factor: 5.614

3.  Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Authors:  Charlotte Cuerq; Emilie Henin; Lioara Restier; Emilie Blond; Jocelyne Drai; Christophe Marçais; Mathilde Di Filippo; Christian Laveille; Marie-Caroline Michalski; Pierre Poinsot; Cyrielle Caussy; Agnès Sassolas; Philippe Moulin; Emmanuelle Reboul; Sybil Charriere; Emile Levy; Alain Lachaux; Noël Peretti
Journal:  J Lipid Res       Date:  2018-07-18       Impact factor: 5.922

Review 4.  Vitamin E inadequacy in humans: causes and consequences.

Authors:  Maret G Traber
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

5.  Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment.

Authors:  Yuandong Ma; Yi Zheng; Kexin Liu; Ge Tian; Yan Tian; Lei Xu; Fei Yan; Laiqiang Huang; Lin Mei
Journal:  Nanoscale Res Lett       Date:  2010-05-06       Impact factor: 4.703

6.  Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and Fullerenes.

Authors:  Aihui Yan; Annette Von Dem Bussche; Agnes B Kane; Robert H Hurt
Journal:  Carbon N Y       Date:  2007-11       Impact factor: 9.594

7.  Effect of a vitamin/mineral supplement on children and adults with autism.

Authors:  James B Adams; Tapan Audhya; Sharon McDonough-Means; Robert A Rubin; David Quig; Elizabeth Geis; Eva Gehn; Melissa Loresto; Jessica Mitchell; Sharon Atwood; Suzanne Barnhouse; Wondra Lee
Journal:  BMC Pediatr       Date:  2011-12-12       Impact factor: 2.125

Review 8.  Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives.

Authors:  Christiana M Neophytou; Andreas I Constantinou
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

9.  TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy.

Authors:  Lan Tang; Wenhui Jiang; Lan Wu; Xiaolan Yu; Zheng He; Weiguang Shan; Lulu Fu; Zhenhai Zhang; Yunchun Zhao
Journal:  Int J Nanomedicine       Date:  2021-12-01

Review 10.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.